Only 11 of 237 Active Dividend Funds Beat SCHD’s Index
A 15-year scorecard just revealed how badly active dividend fund managers fared against a passive benchmark, and the results raise a pointed question about whether the most popular dividend ETF belongs in your portfolio right now.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
A commercial index provider spent 15 years watching active dividend managers try to beat its benchmark, and the scoreboard is unflattering. S&P Dow Jones Indices’ anniversary study, posted September 1, 2026, found the Dow Jones U.S. Dividend 100 Index outperformed 226 of 237 active dividend funds from August 31, 2011 through June 30, 2026.
That is the benchmark tracked by Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD), the fund most retail investors reach for when they want a screened basket of American dividend payers at a rock-bottom fee.
The S&P Dow Jones Indices paper does not identify the eleven winners or spell out fee treatment across share classes, and the index reflects gross returns rather than an investable product. Treat it as a marketing document rather than a verified ranking of SCHD itself. Still, the direction is unmistakable, and it matters because Charles Schwab Asset Management charges 0.06% annually to run this strategy. The question worth asking is whether SCHD’s recipe belongs in your income sleeve today.
And even the 11 outperformers are unlikely to keep outperforming in the next decade and a half, as active ETFs are usually inconsistent performers.
What You Actually Own
SCHD’s index screens U.S. companies with 10 or more years of dividend payments, then ranks survivors on cash-flow-to-debt, return on equity, dividend yield, and five-year dividend growth. The result tilts toward mature cash generators rather than the highest yielders.
The current book reads that way. Top positions include Qualcomm (NASDAQ:QCOM | QCOM Price Prediction) at 6.7%, Texas Instruments (NASDAQ:TXN) at 5.9%, UnitedHealth (NYSE:UNH) at 5.1%, and Coca-Cola (NYSE:KO) near 4%, with energy majors Chevron (NYSE:CVX) and ConocoPhillips (NYSE:COP) filling out the top ten.
The fund pays quarterly. Trailing 12-month distributions totaled $1.048 per share, versus an annualized forward run rate of $1.01, pointing to a yield in the low 3% range against a recent price near $34.
What the Index Beat, and What It Did Not
The 226-of-237 figure is compelling because active dividend funds carry higher expenses and turnover, which compound against them across a 15-year window. Fee drag alone explains much of the gap.
But don’t mistake the benchmark’s record for SCHD’s. The ETF launched in October 2011, and quality-and-yield screening tends to lag growth-led markets. Over the past year, SCHD returned 30.2%, ahead of Vanguard High Dividend Yield ETF (NYSEARCA:VYM) at 17.3% and Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) at 11.9%.
Zoom out five years and the picture inverts. SCHD returned 62%, VYM 76.9%, and VIG 63%. The screened-quality approach earned its keep in some periods and paid for itself in others.
Where the Strategy Pinches
SCHD carries no international exposure, so it delivers a concentrated bet on U.S. dividend payers. If the next decade favors ex-U.S. equities, this fund cannot help you.
The sector tilt runs heavy toward financials, health care, consumer staples, and energy, and light on the mega-cap technology names that have led index returns for years. iShares Core Dividend Growth ETF (NYSEARCA:DGRO), at a 0.08% expense ratio, serves a similar role with a softer value tilt.
Distribution volatility is the other quiet cost. The latest payment came in at $0.2525, down from $0.2569, a reminder that these are not fixed coupons.
Bull and Bear Case for SCHD
The bull case is that a rules-based screen focused on cash-flow quality and dividend durability has already outrun the median active manager for 15 years, and the fee it charges is essentially a rounding error. For an investor building a durable income sleeve, that combination is hard to replicate through security selection.
The bear case is that SCHD’s methodology bakes in a value and old-economy tilt that structurally underweights the market’s fastest-compounding businesses. A retiree who does not need capital appreciation may accept that trade willingly; a 40-year-old dollar-cost averaging for growth probably should not.
Which case wins depends on the next market regime. If leadership broadens beyond mega-cap tech, SCHD looks like a very good core holding. If it doesn’t, a 5% to 10% income sleeve is a reasonable ceiling for this fund in most portfolios.
Contact [email protected] for any questions or corrections.
Omor Ibne Ehsan is a writer at 24/7 Wall St. He is a self-taught investor with a focus on growth, cyclical, and dividend equities that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as penny stocks.
